8-K
Current Report
SELLAS Life Sciences Group, Inc. Filed Acc 0000950123-11-033025
Material agreement · Exit or restructuring costs · Unregistered share sale · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 2.05 Costs associated with exit or disposal activities
- Item 3.02 Unregistered sales of equity securities
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading b85913e8vk.htm…